A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma

NCT00001266 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

NIH

Sponsor class

Conditions

Prostatic Neoplasm

Interventions

DRUG: Suramin

Sponsor

National Cancer Institute (NCI)